Option Care Health Agrees to $5.8 Billion Acquisition by CD&R and McKesson at $32.05 Per Share
Option Care Health (OPCH) agreed to a $32.05 per share cash acquisition by CD&R and McKesson (MCK), valuing the company at $5.8 billion. The deal represents a 37% premium to OPCH's October 5 closing price. CD&R will own 51%, McKesson 49%. The transaction is expected to close in the first half of 2027, subject to shareholder and regulatory approvals.
How this was made
The 30-second read
Why it matters
The acquisition creates a vertically integrated platform for specialty therapies, potentially improving margins and market reach.
Market read
The deal is a material M&A event that will immediately affect OPCH pricing and may modestly influence McKesson's strategic outlook.
What to watch
Potential integration challenges and the impact of future equity‑method accounting on McKesson's earnings.
Background
Option Care Health operates a national network of home and alternate‑site infusion services; McKesson is a leading healthcare services distributor.
Ticker impact
Option Care Health announced a definitive cash acquisition at $32.05 per share, a 37% premium, making the deal the primary news of the article.
upward pressure as the stock trades toward the $32.05 offer price
The deal is newly disclosed, sizable ($5.8 B) and includes a premium, driving immediate price appreciation before the stock ceases trading.
McKesson is a co‑buyer in the $5.8 B acquisition of Option Care Health, committing $1.4 B for a 49% stake.
slight positive pressure as investors value the strategic fit
The transaction adds a new business line but the cash outlay is modest relative to McKesson’s size, so impact is limited.
Market effects
Healthcare services sector may see increased M&A activity as larger players seek home‑infusion capabilities.
U.S. healthcare market gains a larger integrated provider, potentially boosting related stocks.
The deal underscores consolidation trends in global specialty therapy distribution.
Counterpoint
If regulatory approvals stall, the premium could evaporate, leaving investors exposed to a failed transaction.
Key entities
- CompanyOption Care Health
Target of the $5.8 B acquisition.
- CompanyMcKesson Corp.
Co‑buyer committing $1.4 B for a 49% stake.
- Private EquityCD&R
Seller holding 51% post‑deal.
